• Company
• Big Pharma are making all efforts to preoccupy orphan drugs
• by Jul 20, 2022 05:49am

• Company
• Maximizing JW Pharma's platform technology
• by Chon, Seung-Hyun Jul 20, 2022 05:48am

• Company
• Novartis nears reimb for its 2 ultra-high-priced new drugs
• by Eo, Yun-Ho Jul 19, 2022 05:16am

• Company
• Daiichi Sankyo's CSR activities resumed in 3 years
• by Lee, Seok-Jun Jul 19, 2022 05:16am

• Company
• Samsung Bioepis announces effectiveness of Lucentis Similar
• by Kim, Jin-Gu Jul 19, 2022 05:16am

• Company
• NTS will provide tax support for bio companies
• by Kang, Shin-Kook Jul 19, 2022 05:15am

• Company
• Will social distancing resume?
• by Kim, Jin-Gu Jul 19, 2022 05:15am

• Policy
• To halve the death rate from COVID-19
• by Lee, Jeong-Hwan Jul 18, 2022 06:06am

• Opinion
• [Reporter’s View] Secrecy no more in pricing negotiations
• by Eo, Yun-Ho Jul 18, 2022 06:06am

• Policy
• Abbott has filed a suspension of execution with the court
• by Kim, Jung-Ju Jul 18, 2022 06:06am